Breast Cancer
Novel AI model may predict which patients with cancer are at risk for chronic pain
A multi-institutional team of researchers developed an AI model designed to predict which patients with breast cancer are most likely to experience chronic pain.
Clinicians ‘should be open’ to menopausal hormone therapy beyond age 65 years
CHICAGO — Hormone therapy is beneficial for some women beyond age 65 years to treat ongoing menopausal symptoms that affect their quality of life, according to research reported at the Annual Meeting of The Menopause Society.
Medical oncologist and cancer survivorship expert to receive ESMO Award
Ann H. Partridge, MD, MPH, will receive this year’s ESMO Award.
VIDEO: Sequence of treatments for patients with breast cancer ‘continues to evolve’
In this video interview, Sara M. Tolaney, MD, MPH, discusses the individualized sequential therapies provided to patients based on the breast cancer subtype, genomics and other factors.
VIDEO: Rising breast cancer incidence impacts awareness yet ‘there is a need to do better’
In this video interview, Sara M. Tolaney, MD, MPH, highlights the increasing incidence in breast cancer.
VIDEO: Potential of AI in breast cancer diagnostics
In this video interview, Sara M. Tolaney, MD, MPH, highlights the integration of artificial intelligence in radiologic reads to assist technicians in detecting abnormalities during breast cancer screenings.
VIDEO: How providers can ‘do better’ to improve access to care for breast cancer patients
In this video interview, Sara M. Tolaney, MD, MPH, discusses the need to address disparities among patients with breast cancer.
Most women are unaware that healthy diets can help prevent breast cancer
Less than three in 10 women are aware that a healthy diet can help reduce the risk for breast cancer, according to a recent survey.
Top in women’s health: Drop in births, fertility and prenatal care; fetal antigen test
From 2022 to 2023, U.S. birth and fertility rates dropped while the percentage of women receiving no prenatal care rose, according to a report from the CDC.
Insurance status may affect access to high-quality, guideline-concordant cancer care
Insurance status contributes to considerable disparities in care quality for patients with head and neck cancer, according to retrospective study results.